Antibody responses to COVID-19 in lung cancer patients: an interview with Amy Moore

Please introduce yourself, your research background and current research interests. I am Dr Amy Moore, Director of Science & Research for the GO2 Foundation for Lung Cancer (a national organization with offices in Washington, DC and the SF Bay Area). In this role, I oversee GO2 Foundation’s external research portfolio, serve as the primary liaison for research collaborations with various biomarker patient groups and support our research institute, the Addario Lung Cancer Medical Institute (ALCMI; CA, USA), in vetting new scientific opportunities and launching new studies to advance research across the lung cancer care continuum. Prior to joining GO2 Foundation,...